Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 02-2002 | 11-2001 | 08-2001 | 05-2001 | 02-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -383 | -407 | -268 | -516 | -191 |
| Depreciation Amortization | 149 | 108 | 51 | 208 | 170 |
| Accounts receivable | -112 | 39 | -9 | 176 | 257 |
| Other Working Capital | -5 | 35 | 163 | 108 | 260 |
| Other Operating Activity | 220 | -4 | -66 | 190 | -100 |
| Operating Cash Flow | $-130 | $-229 | $-129 | $166 | $395 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 39 | 27 | 6 | 86 | 73 |
| PPE Investments | -8 | -10 | N/A | -62 | -135 |
| Purchase Sale Intangibles | -11 | -11 | N/A | -20 | -16 |
| Other Investing Activity | -13 | -7 | 11 | -23 | -15 |
| Investing Cash Flow | $18 | $9 | $17 | $1 | $-77 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -23 | 33 | 20 | N/A | 855 |
| Debt Issued | N/A | N/A | N/A | 95 | N/A |
| Debt Repayment | 215 | 165 | 130 | N/A | 30 |
| Common Stock Issued | 1 | 1 | N/A | 249 | 59 |
| Other Financing Activity | 4 | 10 | 10 | -4 | 153 |
| Financing Cash Flow | $198 | $209 | $160 | $340 | $1,097 |
| Beginning Cash Position | 136 | 136 | 136 | 613 | 634 |
| End Cash Position | 119 | 54 | 149 | 127 | 234 |
| Net Cash Flow | $-17 | $-82 | $13 | $-486 | $-400 |
| Free Cash Flow | |||||
| Operating Cash Flow | -130 | -229 | -129 | 166 | 395 |
| Capital Expenditure | -8 | -10 | N/A | -62 | -135 |
| Free Cash Flow | -139 | -239 | -129 | 104 | 260 |